These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 24587678)
1. Targeted therapy in gastric cancer: personalizing cancer treatment based on patient genome. Lim SM; Lim JY; Cho JY World J Gastroenterol; 2014 Feb; 20(8):2042-50. PubMed ID: 24587678 [TBL] [Abstract][Full Text] [Related]
2. Molecular diagnosis for personalized target therapy in gastric cancer. Cho JY J Gastric Cancer; 2013 Sep; 13(3):129-35. PubMed ID: 24156032 [TBL] [Abstract][Full Text] [Related]
3. Microarray and next-generation sequencing to analyse gastric cancer. Dang Y; Wang YC; Huang QJ Asian Pac J Cancer Prev; 2014; 15(19):8033-9. PubMed ID: 25338980 [TBL] [Abstract][Full Text] [Related]
4. Identifying molecular drivers of gastric cancer through next-generation sequencing. Liang H; Kim YH Cancer Lett; 2013 Nov; 340(2):241-6. PubMed ID: 23178814 [TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine. Paolillo C; Londin E; Fortina P Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004 [TBL] [Abstract][Full Text] [Related]
6. New therapeutic options opened by the molecular classification of gastric cancer. Chivu-Economescu M; Matei L; Necula LG; Dragu DL; Bleotu C; Diaconu CC World J Gastroenterol; 2018 May; 24(18):1942-1961. PubMed ID: 29760539 [TBL] [Abstract][Full Text] [Related]
7. From standard to new genome-based therapy of gastric cancer. Lianos GD; Mangano A; Cho WC; Roukos DH Expert Rev Gastroenterol Hepatol; 2015; 9(8):1023-6. PubMed ID: 26108988 [TBL] [Abstract][Full Text] [Related]
8. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa. Yamamoto H; Watanabe Y; Maehata T; Morita R; Yoshida Y; Oikawa R; Ishigooka S; Ozawa S; Matsuo Y; Hosoya K; Yamashita M; Taniguchi H; Nosho K; Suzuki H; Yasuda H; Shinomura Y; Itoh F World J Gastroenterol; 2014 Apr; 20(14):3927-37. PubMed ID: 24744582 [TBL] [Abstract][Full Text] [Related]
9. A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice. Vasan N; Yelensky R; Wang K; Moulder S; Dzimitrowicz H; Avritscher R; Wang B; Wu Y; Cronin MT; Palmer G; Symmans WF; Miller VA; Stephens P; Pusztai L Oncologist; 2014 May; 19(5):453-8. PubMed ID: 24710307 [TBL] [Abstract][Full Text] [Related]
10. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161 [TBL] [Abstract][Full Text] [Related]
11. Genomics Study of Gastric Cancer and Its Molecular Subtypes. Yuen ST; Leung SY Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784 [TBL] [Abstract][Full Text] [Related]
12. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. Li T; Kung HJ; Mack PC; Gandara DR J Clin Oncol; 2013 Mar; 31(8):1039-49. PubMed ID: 23401433 [TBL] [Abstract][Full Text] [Related]
13. Gastric cancer and genomics: review of literature. Onoyama T; Ishikawa S; Isomoto H J Gastroenterol; 2022 Aug; 57(8):505-516. PubMed ID: 35751736 [TBL] [Abstract][Full Text] [Related]
14. The Right Treatment of the Right Patient: Integrating Genetic Profiling Into Clinical Decision Making in Advanced Gastric Cancer in Asia. Nakamura Y; Shitara K; Lee J Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-8. PubMed ID: 34010049 [TBL] [Abstract][Full Text] [Related]
15. Translating gastric cancer genomics into targeted therapies. Ang YL; Yong WP; Tan P Crit Rev Oncol Hematol; 2016 Apr; 100():141-6. PubMed ID: 26947813 [TBL] [Abstract][Full Text] [Related]
16. Next-generation Sequencing in the Management of Gastric and Esophageal Cancers. Rubinstein JC; Nicolson NG; Ahuja N Surg Clin North Am; 2019 Jun; 99(3):511-527. PubMed ID: 31047039 [TBL] [Abstract][Full Text] [Related]
17. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives. Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471 [TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells. Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379 [TBL] [Abstract][Full Text] [Related]
20. Dawn of precision medicine on gastric cancer. Ishii T; Kawazoe A; Shitara K Int J Clin Oncol; 2019 Jul; 24(7):779-788. PubMed ID: 30976939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]